<PAGE>
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________________
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
______________________
NOVEMBER 29, 1995
(DATE OF REPORT)
___________________
NOVEMBER 28, 1995
(DATE OF EARLIEST EVENT REPORTED)
___________________
PFIZER INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Delaware 1-3619 13-531570
(State or other jurisdiction (Commission File Number) (I.R.S.
of incorporation) Identification No.)
235 East 42nd Street, New York, New York 10017
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including
area code (212) 573-2323
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. OTHER EVENTS
On November 28, 1995, Pfizer Inc. ("Pfizer") announced that the Supreme Court
declined to review a $63.5 million patent verdict, exclusive of post-judgment
interest, against SciMed Life Systems, Inc., a subsidiary of Boston Scientific
Corp., which was found to have infringed patents held by Pfizer subsidiaries
Schneider [Europe] AG and Schneider [USA] Inc. The Company's press release is
attached hereto as Exhibit 99 and is incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(C) EXHIBITS
EXHIBIT 99. Press release of the Company dated November 28, 1995.
PFIZER INC.
(Registrant)
By: /s/ Terence J. Gallagher
------------------------------------------
Terence J. Gallagher
Vice President - Corporate Governance
Date: November 29, 1995
<PAGE>
For immediate release Contact:
November 28, 1995 Bob Fauteux 212-573-3079
U.S. SUPREME COURT DENIES CERTIORARI,
SUSTAINING PATENT-INFRINGEMENT AWARD TO PFIZER
New York, Nov. 28 -- The United States Supreme Court has declined to review an
appeal by SciMed Life Systems, Inc., a subsidiary of Boston Scientific Corp., of
an award of $63.5 million in damages and interest to Pfizer Inc in a patent
infringement case. The impact of this award is not expected to significantly
affect the company's financial results for 1995.
In denying review of SciMed's appeal, the Supreme Court let stand a federal
judge's earlier finding, confirmed by a U.S. appeals court, that the company had
violated cardiac-catheter patents held by Pfizer subsidiaries Schneider
(USA)Inc, based in Plymouth, Minnesota, and Schneider (Europe) AG in
Switzerland.
"We are pleased with the Court's action in reconfirming the importance of
protecting intellectual property," said Paul S. Miller, senior vice president
and general counsel of Pfizer.
Core businesses in the Pfizer Hospital Products Group, Schneider (USA) and
Schneider (Europe) are rapidly-growing developers and marketers of advanced
products for interventional radiology, cardiology and gastroenterology.
(more)
<PAGE>
-2-
Pfizer Inc is a research-based, diversified health-care company with global
operations. The company reported sales of approximately $8.3 billion for 1994.
# # # # #
